84 Grants (Page 1 of 4)
2020
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA206025-05), $600,622USD, 2016-05-10 -- 2021-04-30
 
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA206025-06), $600,621USD, 2016-05-10 -- 2022-04-30
2019
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA206025-04), $604,910USD, 05/10/2016 -- 04/30/2021
 
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA206025-04S1), $15,365USD, 05/10/2016 -- 04/30/2021
 
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA206025-04S2), $20,000USD, 05/10/2016 -- 04/30/2021
2018
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA206025-03S2), $20,000USD, 05/10/2016 -- 04/30/2021
 
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA206025-03S1), $52,355USD, 05/10/2016 -- 04/30/2021
 
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA206025-03), $630,724USD, 05/10/2016 -- 04/30/2021
 
Role of Bone-Derived TGF-beta in Glucose Metabolism in the Setting of Breast Cancer Bone Metastases
Guise, Theresa
U.S. Department Of Defense (Dod) (ID: W81XWH1810678), $1,181,250USD, 9/15/2018 -- 9/14/2021
2017
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA206025-02), $637,172USD, 05/10/2016 -- 04/30/2021
2016
Effect of Low-Magnitude Mechanical Signals on Breast Cancer Bone Metastases
Guise, Theresa
U.S. Department Of Defense (Dod), United States Army (ID: W81XWH1610040), $857,226USD, 2/1/2016 -- 1/31/2019
 
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
Guise, Theresa A⋅MARKS, ANDREW R and Territo, Paul R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA206025-01), $655,037USD, 05/10/2016 -- 04/30/2021
2015
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
BHOWMICK, NEIL A and Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA143057-05), $537,942USD, 04/07/2011 -- 03/31/2017
2014
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
BHOWMICK, NEIL A and Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA143057-04), $521,804USD, 04/07/2011 -- 03/31/2016
2013
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
BHOWMICK, NEIL A and Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA143057-03), $505,665USD, 04/07/2011 -- 03/31/2016
2012
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
BHOWMICK, NEIL A and Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA143057-02), $537,945USD, 04/07/2011 -- 03/31/2016
 
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA069158-16), $272,224USD, 04/01/1996 -- 11/30/2013
2011
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
BHOWMICK, NEIL A and Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1U01CA143057-01A1), $551,442USD, 04/07/2011 -- 03/31/2016
 
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA069158-15), $272,224USD, 04/01/1996 -- 11/30/2012
2010
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA069158-14), $280,643USD, 04/01/1996 -- 11/30/2012
2009
Cell, Animal and Imaging Core
Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P01CA104106-05-9002), $190,379USD, 2009
 
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
Guise, Theresa A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK065837-05), $155,245USD, 04/01/2005 -- 07/15/2009
 
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
Guise, Theresa A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 7R01DK065837-06), $179,513USD, 04/01/2005 -- 03/31/2011
 
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA069158-13), $276,088USD, 04/01/1996 -- 07/15/2009
2008
Cell, Animal and Imaging Core
Guise, Theresa A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P01CA104106-04-9002), $122,298USD, 08/01/2008 -- 07/31/2010